转化医学平台下提升高等药学院校新药研发水平的思考  

The Thinking of Promoting the Level of Pharmaceutical Universities New Drug Research and Development in Translational Medicine Platform

作　　者：王殉[1] 刘俊义[1] 

机构地区：[1]北京大学药学院,100191

出　　处：《中华医学科研管理杂志》2014年第1期2-4,共3页Chinese Journal of Medical Science Research Management

摘　　要：高等药学院校作为我国新药研发的主力军,担负着研发出具有我国自主知识产权新药的重任.转化医学概念的提出为提高新药研发效率提供了机遇和挑战.目前国内高等药学院校陆续成立的转化医学中心,为促进新药研发提供了切实有益的条件.本文分析了行政管理完善转化医学平台建设,推动新药研发的途径.As the main force of new drug research and development （R＆D） in China,pharmaceutical universities are in charge of developing new drugs with our own intellectual property rights.The concept of translational medicine provides opportunity and challenge to improve the efficiency of new drug R＆D.Several translational medicine centers have been set up in pharmaceutical universities,which provide practical conditions for new drug R＆D in domestic.Administration management approaches to promote new drug R＆D in translational medicine platform are analyzed in the paper.

关 键 词：转化医学 高等药学院校 新药研发 行政管理 

分 类 号：R9-4[医药卫生—药学]